NCM
BSX icon

Northside Capital Management’s Boston Scientific BSX Stock Holding History

Northside Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.91M Sell
158,324
-2,042
-1% -$94.5K 0.55% 53
2026
Q2 		$6.84M Buy
160,366
+49,189
+44% +$2.67M 0.56% 54
2026
Q1 		$6.98M Buy
+111,177
New +$8.89M 0.61% 52

Other funds holding BSX

GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Northside Capital Management's BSX Position: Q3 2026 in Review

Northside Capital Management reduced its Boston Scientific (BSX) stake by 1.3% in Q3 2026, selling an estimated $94.5K and leaving 158,324 shares worth $6.91M. The position accounts for 0.55% of the portfolio, ranked #53.

Northside Capital Management first reported a position in BSX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.98M in Q1 2026. 76 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Northside Capital Management held 158,324 shares of Boston Scientific worth $6.91M as of Q3 2026.
  • Northside Capital Management sold 2,042 Boston Scientific shares in Q3 2026, an estimated $94.5K.
  • Boston Scientific made up 0.55% of Northside Capital Management's portfolio in Q3 2026, its #53 holding.
  • Northside Capital Management first reported a position in Boston Scientific in Q1 2026 and has held it in 3 quarters since.
  • Northside Capital Management's Boston Scientific position peaked at $6.98M in Q1 2026.
  • 76 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Northside Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.